Medcorp Limited (TTSE:MED)
32.00
-0.50 (-1.54%)
At close: Sep 4, 2026
Medcorp Ratios and Metrics
Market cap in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254 | 376 | - | - | - | - | |
Market Cap Growth | -33.67% | - | - | - | - | - |
Enterprise Value | 316 | 440 | - | - | - | - |
Last Close Price | 32.50 | 46.96 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.03 | 20.67 | - | - | - | - |
PS Ratio | 2.05 | 3.09 | - | - | - | - |
PB Ratio | 2.42 | 3.80 | - | - | - | - |
P/TBV Ratio | 2.42 | 3.80 | - | - | - | - |
P/FCF Ratio | 10.96 | 16.51 | - | - | - | - |
P/OCF Ratio | 10.28 | 15.33 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.55 | 3.62 | - | - | - | - |
EV/EBITDA Ratio | 8.52 | 16.27 | - | - | - | - |
EV/EBIT Ratio | 15.16 | 19.73 | - | - | - | - |
EV/FCF Ratio | 13.62 | 19.34 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.83 | 1.02 | 1.58 | 1.52 | 1.19 | 1.15 |
Debt / EBITDA Ratio | 2.54 | 2.62 | 2.92 | 2.60 | 1.10 | 1.19 |
Debt / FCF Ratio | 3.75 | 4.44 | 5.80 | 4.57 | 1.72 | 8.42 |
Net Debt / Equity Ratio | 0.59 | 0.72 | 1.33 | 1.08 | 0.42 | 0.36 |
Net Debt / EBITDA Ratio | 2.71 | 2.62 | 3.43 | 2.10 | 0.43 | 0.40 |
Net Debt / FCF Ratio | 2.66 | 3.11 | 4.87 | 3.26 | 0.62 | 2.63 |
Asset Turnover | 0.59 | 0.53 | 0.50 | 0.64 | 0.88 | 0.86 |
Inventory Turnover | 9.21 | 7.31 | 8.31 | 8.02 | 8.65 | 8.48 |
Quick Ratio | 2.18 | 1.83 | 1.05 | 1.33 | 0.68 | 0.84 |
Current Ratio | 2.48 | 2.09 | 1.20 | 1.45 | 0.78 | 0.94 |
Return on Equity (ROE) | 18.72% | 21.04% | 19.19% | 92.64% | 61.56% | 70.10% |
Return on Assets (ROA) | 5.39% | 6.08% | 5.97% | 12.50% | 14.18% | 16.45% |
Return on Invested Capital (ROIC) | 10.87% | 11.63% | 9.18% | 26.94% | 45.20% | 52.55% |
Return on Capital Employed (ROCE) | 9.70% | 11.70% | 13.20% | 19.60% | 47.60% | 48.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.12% | 4.84% | - | - | - | - |
FCF Yield | 9.13% | 6.06% | - | - | - | - |
Dividend Yield | 6.15% | 4.26% | - | - | - | - |
Payout Ratio | 86.42% | 43.07% | 121.60% | 13.11% | 119.76% | 45.81% |
Buyback Yield / Dilution | -4.34% | -2.34% | - | - | - | - |
Total Shareholder Return | 1.81% | 1.92% | - | - | - | - |